Skip to main content
Clinical Trials/CTRI/2024/04/065593
CTRI/2024/04/065593
Not yet recruiting
Phase 4

To study the efficacy of Probiotics along with Phototherapy and phototherapy alone in neonatal hyperbilirubinemia: A Randomized Controlled Trial

Government Medical College Rajindra Hospital Patiala1 site in 1 country150 target enrollmentStarted: April 26, 2024Last updated:

Overview

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Government Medical College Rajindra Hospital Patiala
Enrollment
150
Locations
1
Primary Endpoint
serum bilirubin level lowering efficacy of probiotics along with phototherapy vs phototheray alone in patients of neonatal hyperbilirubinemia

Overview

Brief Summary

This will be a randomized clinical trial including 150 neonates diagnosed with neonatal hyperbilirubinemia. Patients will be randomized to two groups - phototherapy with oral probiotics (Darolac) and phototherapy alone through stratified randomization. Serum Bilirubin Levels (SBL) at the time of intervention, 24, 48, and 72 hours later, duration of phototherapy, duration of hospitalization, and any side effect related to intervention will be assessed and compared in the two groups

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
1.00 Day(s) to 21.00 Day(s) (—)
Sex
All

Inclusion Criteria

  • Preterm and term neonates with hyperbilirubinemia (35-40 weeks)
  • Patients with jaundice due to maternal blood type ABO compatibility
  • G6PD deficiency
  • Hypothyroidism 5.

Exclusion Criteria

  • Patients with gestational age less than 35 weeks.
  • Patients with severe cardiopulmonary illness.
  • Patients with birth weight less than 2,000 grams.
  • Patients having signs of perinatal asphyxia.
  • Patients with congenital anomalies.
  • Patients whose parents refuse to give written informed consent.

Outcomes

Primary Outcomes

serum bilirubin level lowering efficacy of probiotics along with phototherapy vs phototheray alone in patients of neonatal hyperbilirubinemia

Time Frame: Day-1, 24 hours, 48 hours and 72 hours

Secondary Outcomes

  • change in duration of phototherapy in probiotics along with phototherapy and phototherapy alone treatment group(Day-1, 24 hours, 48 hours and 72 hours)

Investigators

Sponsor
Government Medical College Rajindra Hospital Patiala
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Amanpreet Kaur

Government Medical College & Rajindra Hospital Patiala

Study Sites (1)

Loading locations...

Similar Trials